Quebec Company Permanently Banned from Selling Unauthorized Injectable Products
A Quebec-based company, Canlab Research, has been permanently blocked by a court from selling unauthorized injectable peptides. This legal action follows a long-standing investigation into the company’s business practices and the safety of the products it offered to the public.
Health Canada first took action against the company in 2023. At that time, the government agency issued a formal order for Canlab Research to stop advertising and selling these substances. Officials also released a public warning, advising Canadians that the products had not been approved for safety, quality, or effectiveness.
Injectable peptides are often marketed online for various health or performance-related reasons. However, Health Canada emphasizes that these products can pose serious health risks when they are sold without proper authorization. Because they are injected, they can cause infections or other dangerous side effects if they are not manufactured under strict medical standards.
This court decision serves as a final step in preventing the company from continuing these unauthorized sales. Health Canada continues to remind the public that they should only use health products that have been officially approved for sale in Canada. Consumers can check the Health Canada website to verify if a product is authorized for use.